Alternative therapy of menopausal vegetative disorders in women taking the metabolic status into account

Authors

DOI:

https://doi.org/10.18370/2309-4117.2023.69.80-88

Keywords:

postmenopause, vegetative disorders, Kupperman index, Life extension strategy, carbohydrate metabolism, insulin resistance, lipid metabolism, endothelial protection, L-arginine, xylitol

Abstract

Research objectives: to study the clinical effectiveness of alternative complex therapy of vegetative syndrome in menopausal patients using L-arginine and xylitol drugs.
Materials and methods. The clinical prospective study included 50 patients in the early postmenopausal period with natural menopause, neurovegetative and psychoemotional manifestations of the climacteric syndrome. According to the Life extension strategy, patients received intravenous L-arginine (Tivortin drug) and xylitol solution with electrolytes (Xylat drug) for endothelial protection and correction of insulin resistance in order to treat climacteric syndrome. Modified Kupperman menopausal index, serum triglyceride, cholesterol, high-density lipoprotein, low-density lipoprotein, and very-low-density lipoprotein levels were determined in all women. Examinations were performed before the start of therapy and 3 months after the end of treatment.
Results. The Life extension therapeutic strategy as an alternative comprehensive therapy of the vegetative syndrome in menopausal patients contributed to a reliable reduction of the manifestations of the climacteric syndrome. The advantage of combined therapy involving L-arginine and xylitol was manifested in a significant decrease in diastolic blood pressure (p = 0.043); reduction of the Kupperman index (p = 0.002) and the average score of vasomotor symptoms (p = 0.02). There was also a significant decrease in the serum level of insulin (p = 0.00007), HOMA index (p = 0.01), low-density lipoproteins (p = 0.04), and triglycerides (p = 0.03). The selected therapy was well tolerated during the observation period.
Conclusions. The combined therapy involving L-arginine and xylitol in the early postmenopausal period with neurovegetative and psychoemotional manifestations of the climacteric syndrome had a pronounced clinical effect, which consisted in a significant reduction of vegetative disorders and stabilization of carbohydrate and lipid metabolism. The given therapeutic strategy can be considered as an alternative therapy in patients with climacteric disorders when phytotherapy is ineffective and when there are contraindications or limitations to menopausal hormone therapy. The results of this study showed the safety of the Life extension strategy.

Author Biographies

О.А. Taran, National Pirogov Memorial Medical University, Vinnytsia

MD, associate professor of the Department of Obstetrics and Gynecology No. 1

D.H. Konkov, National Pirogov Memorial Medical University, Vinnytsia

MD, professor, Department of Obstetrics and Gynecology No. 1

O.V. Bulavenko, National Pirogov Memorial Medical University, Vinnytsia

MD, professor, head of the Department of Obstetrics and Gynecology No. 2

T.V. Lobastova, National Pirogov Memorial Medical University, Vinnytsia

PhD, associate professor, Department of Obstetrics and Gynecology No. 1

O.B. Malinina, National Pirogov Memorial Medical University, Vinnytsia

PhD, associate professor, Department of Obstetrics and Gynecology No. 1

N.M. Homon, Vinnytsia Regional Clinical Medical Rehabilitation Center for War Veterans and Radiation Protection of the Population, Vinnytsia

Obstetrician-gynecologist

I.R. Pyvniuk, Clinical maternity hospital No. 1, Vinnytsia

Intern obstetrician-gynecologist

References

  1. Konkov, D.G., Starovier, A.V. “Preventive treatment by L-arginine of gestational endotheliopathy in the first trimester of pregnancy.” Women Health 9 (2012): 92–6.
  2. Konkov, D.H., Taran, О.А., Rud, V.О., Klyvak, V.V. “The features of optimal nonhormonal therapy of vegetative disorders among women with postmenopause.” Reproductive Endocrinology 3.65 (2022): 90–6. DOI: 10.18370/2309-4117.2022.65.90-96
  3. Abbasiniya, H., Bandalizadeh, Z., Vakilian, K.K., et al. “Effect of chamomile extract on sleep disorder in menopausal women.” Iran J Obstet Gynecol Infertil 19 (2016): 1–7. DOI: 10.22038/ijogi.2016.7631
  4. Babakhanian, M., Ghazanfarpour, M., Kargarfard, L., et al. “Effect of aromatherapy on the treatment of psychological symptoms in postmenopausal and elderly women: a systematic review and meta-analysis.” J Menopausal Med 24 (2018): 127–32. DOI: 10.6118/jmm.2018.24.2.127
  5. Baber, R.J., Panay, N., Fenton, A., et al. “IMS Recommendations on women’s midlife health and menopause hormone therapy (MHT).” Climacteric 19.23 (2016): 109–50.
  6. Baecker, N., Boese, A., Schoenau, E., et al. “L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women.” J Bone Miner Res 20.3 (2005): 471–9. DOI: 10.1359/JBMR.041121
  7. Bahri, N., Pourali, L., Esmaeeli, H. “Application of various menopausal symptoms treatment options and its related factors, Gonabad-2016.” Iran J Obstet Gynecol Infertil 19 (2016): 1–8. DOI: 10.22038/ijogi.2016.7796
  8. Blum, A., Hathaway, L., Mincemoyer, R., et al. “Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.” J Am Coll Cardiol 35.2 (2000): 271–6. DOI: 10.1016/s0735-1097(99)00553-7
  9. Blumel, J.E., Castelo-Branco, C., Binfa, L., et al. “Quality of life after the menopause: a population study.” Maturitas 34.1 (2000): 17–23. DOI: 10.1016/s0378-5122(99)00081-x
  10. Boger, R.H. “The pharmacodynamics of L-arginine.” Altern Ther Health Med 20.3 (2014): 48–54.
  11. Cheng, M.-H., Hsu, C.-Y., Wang, S.-J., et al. “The relationship of self-reported sleep disturbance, mood, and menopause in a community study.” Menopause 15.5 (2008): 958–62. DOI: 10.1097/gme.0b013e318160dafa
  12. Collins, P., Rosano, G., Casey, C., Daly, C. “Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.” Eur Heart J 28.16 (2007): 2028–40. DOI: 10.1093/eurheartj/ehm296
  13. Cramer, H., Peng, W., Lauche, R. “Yoga for menopausal symptoms – a systematic review and meta-analysis.” Maturitas 109 (2018): 13–25. DOI: 10.1016/j.maturitas.2017.12.005
  14. Cylwik, D., Mogielnicki, A., Buczko, W. “L-arginine and cardiovascular system.” Pharmacol Rep 57.1 (2005): 14–22.
  15. Dehghan, M., Isari, Z., Abbaszadeh, M.H., Ghonchehpour, A. “Menopause symptoms in women and its relation with using complementary and alternative medicines: A survey in southeast Iran.” Front Public Health 10 (2022): 947061. DOI: 10.3389/fpubh.2022.947061
  16. Elsabagh, E.E.M., Allah, E.S.A. “Menopausal symptoms and the quality of life among pre/post menopausal women from rural area in Zagazig city.” Life Sci J 9.2 (2012): 283–91.
  17. Fait, T. “Menopause hormone therapy: latest developments and clinical practice.” Drugs Context 8 (2019): 212551. DOI: 10.7573/dic.212551
  18. Gladwin, M.T., Kim-Shapiro, D.B. “Vascular biology: Nitric oxide caught in traffic.” Nature 491.7424 (2012): 344–5. DOI: 10.1038/nature11640
  19. http://www.socbdr.org/rds/authors/unit_tables_ conversions_and_genetic_dictionaries/conversion_in_si_un.
  20. Xylat®. Compendium – Medicinal Preparations. Available from: [https://compendium.com.ua/dec/261775/].
  21. Ministry of Health of Ukraine. Order from 17.06.2022 No. 1039 “Unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care “Menopausal disorders and other disorders in the perimenopausal period”. Available from: [https://www. medsprava1.com.ua/files/news-medsprava/5435/37474- dn_1039_17_06_2022_dod.pdf].
  22. Ilankoon, I.M.P.S., Samarasinghe, K., Elgan, C. “Menopause is a natural stage of aging: a qualitative study.” BMC Womens Health 21.1 (2021): 47. DOI: 10.1186/s12905-020-01164-6
  23. Inwald, E.C., Albring, C., Baum, E., et al. “Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020).” Geburtshilfe Frauenheilkd 81.6 (2021): 612–36. DOI: 10.1055/a-1361-1948
  24. Khalaf, D., Kruger, M., Wehland, M., et al. “The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure.” Nutrients 11.7 (2019): 1679. DOI: 10.3390/nu11071679
  25. Kim, M.J., Yim, G., Park, H.Y. “Vasomotor and physical menopausal symptoms are associated with sleep quality.” PloS One 13.2 (2018): e0192934.
  26. Klawitter, J., Hildreth, K.L., Christians, U., et al. “A relative L-arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition.” Physiol Rep 5.17 (2017): e13409. DOI: 10.14814/phy2.13409
  27. Kunadian, V., Chieffo, A., Camici, P.G., et al. “An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with european society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders International Study Group.” Eur Heart J 41.37 (2020): 3504–20. DOI: 10.1093/eurheartj/ehaa503
  28. Lakhno, I. “State of metabolic processes and ways to improve them in premenopausal women due to the life extension strategy.” Reproductive Endocrinology 61 (2021): 51–4. DOI: 10.18370/2309-4117.2021.61.51-54
  29. Lund, K.S., Siersma, V., Brodersen, J., Waldorff, F.B. “Efficacy of a standardised acupuncture approach for women with bothersome menopausal symptoms: a pragmatic randomised study in primary care (the ACOM study).” BMJ Open 9.1 (2019): e023637. DOI: 10.1136/bmjopen-2018-023637
  30. Maas, A.H.E.M., Rosano, G., Cifkova, R., et al. “Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.” Eur Heart J 42.10 (2021): 967–84. DOI: 10.1093/eurheartj/ehaa1044
  31. Nair, A.R., Pillai, A.J., Nair, N. “Cardiovascular changes in menopause.” Curr Cardiol Rev 17.4 (2021): e230421187681. DOI: 10.2174/1573403X16666201106141811
  32. Naseri, R., Farnia, V., Yazdchi, K., et al. “Comparison of Vitex agnus-castus extracts with placebo in reducing menopausal symptoms: A Randomized Double-Blind Study.” Korean J Fam Med 40.6 (2019): 362–7. DOI: 10.4082/kjfm.18.0067
  33. Nedashkivsky, S., Halushko, O. “Disorders of carbohydrate metabolism in critical conditions.” Infusion Chemother 3.1 (2020): 52–3. DOI: 10.32902/2663-0338-2020-3.1-44
  34. Puga, G.M., Novais, I.P., Katsanos, C.S., Zanesco, A. “Combined effects of aerobic exercise and l-arginine ingestion on blood pressure in normotensive postmenopausal women: A crossover study Randomized Controlled Trial.” Life Sci 151 (2016): 323–9. DOI: 10.1016/j.lfs.2016.02.091
  35. Rodrigues, I.F., Freitas, G.C. do N., Oliveira, M.M. de, et al. “Impact of hydrotherapy on the quality of life of menopausal women.” Res Soc Dev 9 (2020): e62985292. DOI: 10.33448/rsd-v9i8.5292
  36. Santoro, N., Epperson, C.N., Mathews, S.B. “Menopausal symptoms and their management.” Endocrinol Metab Clin North Am 44.3 (2015): 497–515. DOI: 10.1016/j.ecl.2015.05.001
  37. Sarayloo, K., Latifnejad Roudsari, R. “Critical evaluation of the published clinical trials regarding the effect of complementary medicine on menopausal symptoms.” Iran J Obstet Gynecol Infertil 21 (2018): 87–98. DOI: 10.22038/ijogi.2018.11231
  38. Sharman Moser, S., Chodick, G., Bar-On, S., Shalev, V. “Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis.” Int J Womens Health 12 (2020): 445–54. DOI: 10.2147/IJWH.S246113
  39. Siasos, G., Tousoulis, D., Antoniades, C., et al. “L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?” Int J Cardiol 116.3 (2007): 300–8. DOI: 10.1016/j.ijcard.2006.04.062
  40. Soleymani, M., Siassi, F., Qorbani, M., et al. “Dietary patterns and their association with menopausal symptoms: a cross-sectional study.” Menopause 26 (2019): 365–72. DOI: 10.1097/GME.0000000000001245
  41. Zamaniyan, M., Moosazadeh, M., Peyvandi, S., et al. “Age of natural menopause and related factors among the Tabari Cohort.” J Menopausal Med 26.1 (2020): 18–23. DOI: 10.6118/jmm.19004
  42. Arora, S., Veves, A., Caballaro, A.E., et al. “Estrogen improves endothelial function.” J Vasc Surg 27.6 (1998): 1141–6; discussion 1147. DOI: 10.1016/s0741-5214(98)70016-3
  43. Konkov, D., Belkania, G., Dilenyan, L., et al. Gestational Endotheliopathy as Trigger Disorder of Haemodynamics Pregnancy Supply. Preeclampsia. Ed. H. Abduljabbar. London: IntechOpen (2022). DOI: 10.5772/intechopen.100737. Available from: [https://www.intechopen.com/chapters/79595], last accessed Feb 17, 2022.
  44. Konkov, D.G., Belkania, G.S., Piskun, A.O., Adamchuk, N.V. The features of hemodynamic pregnancy support witn gestational endotheliopathy. The proceedings of the 28th European Congress of Perinatal Medicine ECPM. Lisbon, 22–25 of June 2022. Lisbon (Portugal) (2022): 64–7. DOI: 10.13140/RG.2.2.15134.20802
  45. Somani, Y.B., Pawelczyk, J.A., De Souza, M.J., et al. “Aging women and their endothelium: probing the relative role of estrogen on vasodilator function.” Am J Physiol Heart Circ Physiol 317.2 (2019): H395-H404. DOI: 10.1152/ajpheart.00430.2018

Downloads

Published

2023-09-29

How to Cite

Taran О., Konkov, D., Bulavenko, O., Lobastova, T., Malinina, O., Homon, N., & Pyvniuk, I. (2023). Alternative therapy of menopausal vegetative disorders in women taking the metabolic status into account. REPRODUCTIVE ENDOCRINOLOGY, (69), 80–88. https://doi.org/10.18370/2309-4117.2023.69.80-88

Issue

No. 69 (2023)

Section

Management of menopause

License

Copyright (c) 2023 О.А. Таран, Д.Г. Коньков, О.В. Булавенко, Т.В. Лобастова, О.Б. Малініна, Н.М. Гомон, І.Р. Пивнюк

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.